Skip to content

Author

Shigetaka Kageyama

We have 3 of 14 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Serial Changes in Left Ventricular Ejection Fraction After Transcatheter Aortic Valve Implantation: Associations With Ischemic Heart Disease and Left Ventricular End‐Diastolic Diameter

Left ventricular ejection fraction (LVEF) recovery after transcatheter aortic valve implantation (TAVI) varies among patients with severe aortic stenosis and reduced LVEF. We characterized serial changes in LVEF and examined their associations with ischemic heart disease (IHD) and baseline left ventricular end‐diastoli...

Koji Tanaka, Shigetaka Kageyama, H. Sugiyama et al. · 0 citations
Sep 2026

Cumulative LDL cholesterol exposure after percutaneous coronary intervention is associated with major adverse cardiovascular events.

BACKGROUND AND AIMS We assessed whether AUC-derived cumulative low-density lipoprotein cholesterol (LDL-C) exposure after percutaneous coronary intervention (PCI) was associated with subsequent major adverse cardiac and cerebrovascular events (MACCE), and compared this longitudinal metric with the latest LDL-C measurem...

Shigetaka Kageyama, H. Sugiyama, K. Murata et al. · 0 citations
Open access Jul 2026

Validated 1-Year Mortality Prediction in Patients with Three-Vessel Disease Undergoing Contemporary PCI: Insights from the Multivessel TALENT trial.

In contemporary PCI for 3VD, the LCSS showed moderate discrimination for 1-year all-cause mortality while overestimating its absolute risk, although observed mortality increased across predicted-risk quintiles.

A. Oshima, N. Kanehama, D. van Klaveren et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.